Safety of NovoMix® 30 or Levemir® for Treatment of Type 2 Diabetics in Macedonia

NCT00842894 · clinicaltrials.gov ↗
COMPLETED
Status
3421
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novo Nordisk A/S